US 10206877
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted A61KA61K31/404A61K31/443
Quick answer
US patent 10206877 (Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/404, A61K31/443, A61K31/47, A61K31/4709